FWM
NMTR

Frontier Wealth Management’s 9 Meters Biopharma NMTR Stock Holding History

Frontier Wealth Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$8K Hold
1,500
– – ﹤0.01% 391
2022
Q1 		$15K Buy
1,500
+250
+20% +$3.41K ﹤0.01% 402
2021
Q4 		$24K Buy
1,250
+250
+25% +$5.59K ﹤0.01% 423
2021
Q3 		$26K Hold
1,000
– – ﹤0.01% 418
2021
Q2 		$22K Hold
1,000
– – ﹤0.01% 422
2021
Q1 		$23K Buy
+1,000
New +$30.7K ﹤0.01% 379

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Frontier Wealth Management's NMTR Position: Q2 2022 in Review

Frontier Wealth Management held its 9 Meters Biopharma (NMTR) position steady in Q2 2022 at 1,500 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Frontier Wealth Management first reported a position in NMTR in Q1 2021 and has held it in 6 quarters since. The position peaked at $26K in Q3 2021. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • Frontier Wealth Management held 1,500 shares of 9 Meters Biopharma worth $8K as of Q2 2022.
  • Frontier Wealth Management left its 9 Meters Biopharma share count unchanged in Q2 2022.
  • 9 Meters Biopharma made up ﹤0.01% of Frontier Wealth Management's portfolio in Q2 2022, its #391 holding.
  • Frontier Wealth Management first reported a position in 9 Meters Biopharma in Q1 2021 and has held it in 6 quarters since.
  • Frontier Wealth Management's 9 Meters Biopharma position peaked at $26K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.